Search Results - Benjamin Lockshin

  • Showing 1 - 4 results of 4
Refine Results
  1. 1

    Clinically Meaningful Responses to Dupilumab Among Children Aged 6 Months to 5 Years with Moderate-to-severe Atopic Dermatitis who did Not Achieve Clear or Almost Clear Skin Accord... by Michael J. Cork, Benjamin Lockshin, Andreas Pinter, Zhen Chen, Brad Shumel, Randy Prescilla

    Published in Acta Dermato-Venereologica (2024-02-01)
    Get full text
    Article


  2. 2

    The Efficacy and Safety of Bimekizumab for Plaque Psoriasis: An Expert Consensus Panel by Joshua Burshtein, Milaan Shah, Danny Zakria, Benjamin Lockshin, Jeff Crowley, Joseph F. Merola, Ken Gordon, Mona Shahriari, Neil J. Korman, Raj Chovatiya, Robert Kalb, Mark Lebwohl

    Published in Dermatology and Therapy (2024-02-01)
    Get full text
    Article


  3. 3

    A Descriptive, Post Hoc Analysis of Efficacy and Safety of Risankizumab in Diverse Racial and Ethnic Patient Populations With Moderate-to-Severe Psoriasis by Andrew F. Alexis, Melinda Gooderham, Shawn G. Kwatra, Ahmad Amin, Susan Taylor, Ramon Espaillat, Trisha Rettig, Tianshuang Wu, Linyu Shi, Mark I. Kaldas, Deanne M. Dilley, Ranjeeta Sinvhal, Chudy Nduaka, Benjamin Lockshin

    Published in Dermatology and Therapy (2024-10-01)
    Get full text
    Article


  4. 4

    Chronic inflammation in psoriasis promotes visceral adiposity associated with noncalcified coronary burden over time by Aparna Sajja, Khaled M. Abdelrahman, Aarthi S. Reddy, Amit K. Dey, Domingo E. Uceda, Sundus S. Lateef, Alexander V. Sorokin, Heather L. Teague, Jonathan Chung, Joshua Rivers, Aditya A. Joshi, Youssef A. Elnabawi, Aditya Goyal, Justin A. Rodante, Andrew Keel, Julie E. Alvarez, Benjamin Lockshin, Ronald Prussick, Evan Siegel, Martin P. Playford, Marcus Y. Chen, David A. Bluemke, Joel M. Gelfand, Nehal N. Mehta

    Published in JCI Insight (2020-11-01)
    Get full text
    Article


Search Tools: